SCHEMBL3680608

SCHEMBL3680608

N#CC(=NO)c1c(F)cccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.41
CES1 P23141 2/20 0.41
ALDH1A1 P00352 4/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 3/20 0.37
HTT P42858 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 2/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 2/20 0.31
CUL4A Q13619 1/20 0.30
JAK2 O60674 1/20 0.30
JAK1 P23458 1/20 0.30
TYK2 P29597 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3680605 1.00 CES2 (0.41) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL3678610 0.87 GAA (0.41) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL3678608 0.87 GAA (0.41) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL10753337 0.78 CES2 (0.43) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL10753333 0.78 CES2 (0.43) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL3682739 0.75 ALDH1A1 (0.45) ALDH1A1LMNAMAPTHTTSMN1; SMN2
SCHEMBL3682737 0.75 ALDH1A1 (0.45) ALDH1A1LMNAMAPTHTTSMN1; SMN2
SCHEMBL15066533 0.75 CES2 (0.47) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL15066534 0.75 CES2 (0.47) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL13955584 0.72 CES2 (0.40) CES2CES1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7727967-B2 Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines BOISE STATE UNIVERSITY (US) 2010-06-01 US claimed
US-20080182804-A1 CYANOOXIME INHIBITORS OF CARBONYL REDUCTASE AND METHODS OF USING SAID INHIBITORS IN TREATMENTS INVOLVING ANTHRACYCLINES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-07-31 US claimed
US-7781412-B2 Biphenyl inhibitors of carbonyl reductase BOISE STATE UNIVERSITY (US) 2010-08-24 US disclosed
US-7727967-B2 Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines BOISE STATE UNIVERSITY (US) 2010-06-01 US disclosed
WO-2009048760-A2 BIPHENYL INHIBITORS OF CARBONYL REDUCTASE BOISE STATE UNIVERSITY (US) 2009-04-16 WO disclosed
US-20080227731-A1 BIPHENYL INHIBITORS OF CARBONYL REDUCTASE BOISE STATE UNIVERSITY (US) 2008-09-18 US disclosed
US-20080182804-A1 CYANOOXIME INHIBITORS OF CARBONYL REDUCTASE AND METHODS OF USING SAID INHIBITORS IN TREATMENTS INVOLVING ANTHRACYCLINES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-07-31 US disclosed
US-20080182804-A1 CYANOOXIME INHIBITORS OF CARBONYL REDUCTASE AND METHODS OF USING SAID INHIBITORS IN TREATMENTS INVOLVING ANTHRACYCLINES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-07-31 US disclosed